Pfizer Quote - PFE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

29.16

Bid

Ask

Volume

7,790

0.00 Day's Range 0.00

25.20 52 Week Range 33.92

Market Cap

165.241B

Previous Close

29.16

Open

Last Trade

29.18

Last Trade Time

03:41:29

Financial Volume

VWAP

Average Volume (3m)

30,795,857

Shares Outstanding

5,666,695,064

Dividend Yield

5.76%

PE Ratio

77.99

Earnings Per Share (EPS)

0.37

Revenue

58.5B

Net Profit

2.12B

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.pfizer.com

Headquarters

New York, New York, USA

Founded

Pfizer Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker PFE. The last closing price for Pfizer was US$29.16. Over the last year, Pfizer shares have traded in a share price range of US$ 25.20 to US$ 33.92.

Pfizer currently has 5,666,695,064 shares outstanding. The market capitalization of Pfizer is US$165.24 billion. Pfizer has a price to earnings ratio (PE ratio) of 77.99.

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

216,67%

Buys / Sells

52,78%

OTM / ITM

58,33%

Sweeps Ratio

0,00%

Form 4 - Statement of changes in beneficial ownership of securities

U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors

HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis and on-demand treatment in eligible patients with hemophilia A or...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.21	-0.715015321757	29.37	30.43	28.95	36041752	29.45879815	CS
4	-0.41	-1.38654041258	29.57	30.43	28.26	30061093	29.26611359	CS
12	-0.95	-3.15509797409	30.11	31.54	27.85	30795857	29.40101924	CS
26	3.25	12.5434195291	25.91	31.54	25.2	33818844	28.51779151	CS
52	-3.67	-11.1787998782	32.83	33.92	25.2	37987334	28.34845012	CS
156	-12.4	-29.8363811357	41.56	61.71	25.2	30225484	38.83977362	CS
260	-7	-19.3584070796	36.16	61.71	25.2	30169128	38.50035286	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AMTDAMTD IDEA Group	US$ 1.78 (21.09%)	1
DXYZDestiny Tech100 Inc	US$ 11.49 (15.13%)	105.59k
BLNDBlend Labs Inc	US$ 3.97 (9.07%)	601
SRFMSurf Air Mobility Inc	US$ 2.19 (6.83%)	6.14k
NRDYNerdy Inc	US$ 1.06 (6.82%)	500
YSGYatsen Holding Limited	US$ 3.20 (-14.89%)	21
LNGCheniere Energy Inc	US$ 179.61 (-5.88%)	62
NTGTortoise Midstream Energy Fund Inc	US$ 48.12 (-4.24%)	8
XPEVXPeng Inc	US$ 12.38 (-4.03%)	113.48k
BAHBooz Allen Hamilton Holding Corporation	US$ 155.00 (-3.62%)	9
NIONIO Inc	US$ 6.13 (-1.76%)	292.43k
IONQIonQ Inc	US$ 10.62 (-0.38%)	114.85k
XPEVXPeng Inc	US$ 12.38 (-4.03%)	113.48k
DXYZDestiny Tech100 Inc	US$ 11.49 (15.13%)	105.59k
ALTMArcadium Lithium plc	US$ 5.545 (-0.27%)	69.05k